Aadi Bioscience Announces FDA Approval of its First Product FYARRO™ for Patients with…
FYARRO is the first and only approved therapy for adults for the treatment of malignant PEComa, an ultra-rare and aggressive form of sarcoma with a strong female predominanceFYARRO launch…